Evidence for ongoing brain injury in human immunodeficiency virus–positive patients treated with antiretroviral therapy

References

• Agartz I, Brag S, Franck J, Hammarberg A, Okugawa G, Svinhufvud K, Bergman H. Mr volumetry during acute alcohol withdrawal and abstinence: a descriptive study. Alcohol Alcohol 2003; 38: 71–78
   PubMed Web of Science ®Google Scholar
• Ances BM, Roc AC, Wang J, Korczykowski M, Okawa J, Stern J, Kim J, Wolf R, Lawler K, Kolson DL, Detre JA. Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology 2006; 66: 862–866
   Web of Science ®Google Scholar
• Aylward, EH, Henderer, JD, McArthur, JC, PD Brettschneider, Harris, GJ, Barta, PE, Pearlson, GD. 1993. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology: 2099–2104.
   Google Scholar
• Berman S, O'Neill J, Fears S, Bartzokis G, London ED. Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci 2008; 1141: 195–220
   PubMed Web of Science ®Google Scholar
• Cardenas VA, Studholme C, Gazdzinski S, Durazzo TC, Meyerhoff DJ. Deformation-based morphometry of brain changes in alcohol dependence and abstinence. Neuroimage 2007; 34: 879–887
   PubMed Web of Science ®Google Scholar
• Cardenas VA, Studholme C, Meyerhoff DJ, Song E, Weiner MW. Chronic active heavy drinking and family history of problem drinking modulate regional brain tissue volumes. Psychiatry Res 2005; 138: 115–130
   Google Scholar
• Chang L, Ernst T, Witt MD, Ames N, Walot I, Jovicich J, DeSilva M, Trivedi N, Speck O, Miller EN. Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antivir Ther 2003; 8: 17–26
   PubMed Web of Science ®Google Scholar
• Chao LL, Cardenas VA, Meyerhoff DJ, Rothlind JC, Flenniken DL, Lindgren JA, Weiner MW. Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy. Neuroreport 2003; 14: 2111–2115
   PubMedGoogle Scholar
• Chui, HC. 2000. Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury. In:. Neurologic clinics of North America. ST DeKosky, Philadelphia: WB Saunders, J Neurol Clin, 18: 951–978.
   Google Scholar
• Di Sclafani V, Mackay RD, Meyerhoff DJ, Norman D, Weiner MW, Fein G. Brain atrophy in HIV infection is more strongly associated with CDC clinical stage than with cognitive impairment. J Int Neuropsychopharmacol Soc 1997; 3: 276–287
   PubMedGoogle Scholar
• Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 2007; 8: 33–44
   PubMed Web of Science ®Google Scholar
• Fein G, Di Sclafani V, Meyerhoff DJ. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend 2002; 68: 87–93
   PubMed Web of Science ®Google Scholar
• Fortin C, Joly V. Efavirenz for HIV-1 infection in adults: an overview. Expert Rev Anti Infect Ther 2004; 2: 671–84
   PubMedGoogle Scholar
• Gallo RC, Montagnier L. The discovery of HIV as the cause of AIDS. N Engl J Med 2003; 349: 2283–2285
   PubMed Web of Science ®Google Scholar
• Hestad K, McArthur JH, Pan GJD, Selnes OA, Nance-Sproson TE, Aylward E, Mathews VP, McArthur JC. Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand 1993; 88: 112–118
   PubMed Web of Science ®Google Scholar
• Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters DD. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation 2004; 109: 316–319
   PubMed Web of Science ®Google Scholar
• Jernigan TJ, Archibald S, hesselink JR, Atkinson JH, et al. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Arch Neurol 1993; 50: 250–255
   PubMed Web of Science ®Google Scholar
• Lim KO, Wozniak JR, Mueller BA, Franc DT, Specker SM, Rodriguez CP, Silverman AB, Rotrosen JP. Brain macrostructural and microstructural abnormalities in cocaine dependence. Drug Alcohol Depend 2008; 92: 164–172
   PubMed Web of Science ®Google Scholar
• Matochik JA, Eldreth DA, Cadet JL, Bolla KI. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 2005; 77: 23–30
   PubMed Web of Science ®Google Scholar
• Meyerhoff D. Examining the link between alcohol and HIV/AIDS: studies of CNS effects. Alcohol Res Health 2001a; 25: 288–298
   PubMedGoogle Scholar
• Meyerhoff, D, Cardenas, V, Song, E, Truran, D, Blumenfeld, R, Ezekiel, F, Studholme, C, Rothlind, JC, Lindgren, JA, Weiner, M. 2003a. Brain morphologic changes suggest persistent brain injury in treated HIV-seropositive patients. In:. ISMRM: Toronto. Proc Intl Soc Mag Reson Med. 11: p. 278.
   Google Scholar
• Meyerhoff DJ. Effects of alcohol and HIV infection on the central nervous system. Alcohol Res Health 2001b; 25: 288–298
   PubMedGoogle Scholar
• Meyerhoff DJ, Cardenas V, Studholme C, Blumenfeld R, Truran D, Ezekiel F, Lampiris H, Rothlind J, Lindgren J, Weiner MW. Evidence for brain damage in treated HIV-infected individuals. Neurology 2003b; 60: A186
   Google Scholar
• Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 171–177
   PubMed Web of Science ®Google Scholar
• Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS 2005; 19: 1351–1359
   Google Scholar
• Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 2002; 15: 1–25
   PubMed Web of Science ®Google Scholar
• O'Neill J, Cardenas VA, Meyerhoff DJ. Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging. Addict Biol 2001; 6: 347–361
   Google Scholar
• Osborne A. Diagnostic neuroradiology. Mosby, St. Louis 1994
   Google Scholar
• Pan GJD, McArthur JH, Alyward E, Selnes OA, Nance-Sproson TE, Kumar AJ, Mellits ED, McArthur JC. Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 1992; 42: 2125–2130
   Google Scholar
• Pfefferbaum A, Sullivan EV, Mathalon DH, Shear PK, Rosenbloom MJ, Lim KO. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res 1995; 19: 1177–1191
   PubMed Web of Science ®Google Scholar
• Pinheiro J, Bates D. Mixed-effects models in S and S-PLUS. Springer-Verlag, New York 2000
   Google Scholar
• Quickfall J, Crockford D. Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 2006; 18: 318–332
   PubMed Web of Science ®Google Scholar
• Raposo G, Moore M, Innes D, Leijendekker R, Leigh-Brown A, Benaroch P, Geuze H. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 2002; 3: 718–729
   PubMed Web of Science ®Google Scholar
• Roc AC, Ances BM, Chawla S, Korczykowski M, Wolf RL, Kolson DL, Detre JA, Poptani H. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Arch Neurol 2007; 64: 1249–1257
   Google Scholar
• Rothlind JC, Greenfield TM, Bruce AV, Meyerhoff DJ, Flenniken DL, Lindgren JA, Weiner MW. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc 2005; 11: 70–83
   PubMed Web of Science ®Google Scholar
• Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, Grant I. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV + ) individuals taking nucleoside reverse transcriptase inhibitors. J NeuroVirol 2005; 11: 356–364
   PubMed Web of Science ®Google Scholar
• Shibuyama S, Gevorkyan A, Yoo U, Tim S, Dzhangiryan K, Scott JD. Understanding and avoiding antiretroviral adverse events. Curr Pharm Des 2006; 12: 1075–1090
   PubMed Web of Science ®Google Scholar
• Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, McCutchan JA, Wallace MR, Atkinson JH, Grant I. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol 1998; 55: 161–168
   PubMedGoogle Scholar
• Studholme C, Drapaca C, Iordanova B, Cardenas V. Deformation based mapping of volume change from serial brain MRI in the presence of local tissue contrast change. IEEE Trans Med Imaging 2006; 25: 626–639
   PubMed Web of Science ®Google Scholar
• Tanabe J, Tregellas JR, Dalwani M, Thompson L, Owens E, Crowley T, Banich M. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol Psychiatry 2009; 65: 160–164
   PubMed Web of Science ®Google Scholar
• Thompson PM, Dutton RA, Hayashi KM, Lu A, Lee SE, Lee JY, Lopez OL, Aizenstein HJ, Toga AW, Becker JT. 3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage 2006; 31: 12–23
   Web of Science ®Google Scholar
• Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A 2005; 102: 15647–1552
   PubMed Web of Science ®Google Scholar
• Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028–6036
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 2007; 45: 174–182
   PubMed Web of Science ®Google Scholar
• Tucker KA, Robertson KR, Lin W, Smith JK, An H, Chen Y, Aylward SR, Hall CD. Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol 2004; 157: 153–162
   PubMedGoogle Scholar
• Worsley KJ, Liao CH, Aston J, Petre V, Duncan GH, Morales F, Evans AC. A general statistical analysis for fMRI data. Neuroimage 2002; 15: 1–15
   PubMed Web of Science ®Google Scholar